125 related articles for article (PubMed ID: 455220)
1. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
[No Abstract] [Full Text] [Related]
2. Relationship of herpes simplex virus type-2 antibodies and squamous dysplasia to cervical carcinoma in situ.
Thomas DB; Rawls WE
Cancer; 1978 Dec; 42(6):2716-25. PubMed ID: 215294
[TBL] [Abstract][Full Text] [Related]
3. Cellular hypersensitivity in patients with squamous cell carcinoma of the cervix.
Chen SS; Koffler D; Cohen CJ
Am J Obstet Gynecol; 1975 Jan; 121(1):91-5. PubMed ID: 1115121
[TBL] [Abstract][Full Text] [Related]
4. Cellular immunity as a host response to squamous carcinoma of the cervix.
Goldstein MS; Shore B; Gusberg SB
Am J Obstet Gynecol; 1971 Nov; 111(6):751-5. PubMed ID: 5166388
[No Abstract] [Full Text] [Related]
5. The immunohistological demonstration of carcinoembryonic antigen in intra-epithelial and invasive squamous carcinoma of the cervix.
McDicken IW; Rainey M
Histopathology; 1983 Jul; 7(4):475-85. PubMed ID: 6350149
[TBL] [Abstract][Full Text] [Related]
6. Antibody to genital herpes simplex virus: association with cervical atypia and carcinoma in situ.
Aurelian L; Royston I; Davis HJ
J Natl Cancer Inst; 1970 Sep; 45(3):455-64. PubMed ID: 4331639
[No Abstract] [Full Text] [Related]
7. Cell-mediated immunity in patients with ovarian carcinoma.
Chen SY; Koffler D; Cohen CJ
Am J Obstet Gynecol; 1973 Feb; 115(4):467-70. PubMed ID: 4346615
[No Abstract] [Full Text] [Related]
8. A study of herpes simplex type 2 antibody status in groups of patients with cervical neoplasia in Czechoslovakia.
Janda Z; Kanka J; Vonka V; Svoboda B
Int J Cancer; 1973 Nov; 12(3):626-30. PubMed ID: 4364794
[No Abstract] [Full Text] [Related]
9. Rosette formation and inhibition in cervical dysplasia and carcinoma in situ.
Sawanobori S; Ashman RB; Nahmias AJ; Benigno BB; LaVia MF
Cancer Res; 1977 Dec; 37(12):4332-5. PubMed ID: 922724
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immunity in patients with cervical cancer.
Cerni C; Tatra G; Berger R; Micksche M
Oncology; 1979; 36(4):164-70. PubMed ID: 224356
[TBL] [Abstract][Full Text] [Related]
11. [Genital herpes and cervical cancer].
Grebeniuk BN; Shuvaeva NI; Grigor'ev VV; Posevaia TA; Shubladze AK
Vestn Dermatol Venerol; 1981 Feb; (2):9-12. PubMed ID: 6261479
[No Abstract] [Full Text] [Related]
12. Cell-mediated immunity to encephalitogenic factor (MMI test) in women with cervical dysplasia and carcinoma in situ: the effects of serum.
Flavell DJ; Singer A; Potter CW
Br J Cancer; 1978 Sep; 38(3):396-400. PubMed ID: 81675
[TBL] [Abstract][Full Text] [Related]
13. [Immunoperoxidase demonstration of papillomavirus antigen in dysplasia of the uterine cervix].
Toki T; Oikawa N; Tase T; Wada Y; Yajima A; Suzuki M; Higashiiwai H
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):411-5. PubMed ID: 2984298
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immune responses to cytomegalovirus in patients with dysplasia of the uterine cervix.
Neill WA; Norval M
Gynecol Obstet Invest; 1985; 20(2):96-102. PubMed ID: 2997004
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
McDonald AD; Williams MC; Manfreda J; West R
Am J Epidemiol; 1974 Aug; 100(2):130-5. PubMed ID: 4368955
[No Abstract] [Full Text] [Related]
16. Antigenic deletion in cervical neoplasia.
Ashley C; Kirkland JA; Stanley MA
Pathology; 1974 Oct; 6(4):329-35. PubMed ID: 4615290
[No Abstract] [Full Text] [Related]
17. Dinitrochlorobenzene reactivity of women with cancer of the ovary, cervix and corpus uteri.
Khoo SK; Mackay E; Daunter B
Int J Gynaecol Obstet; 1978 Jul-1979 Aug; 17(1):58-62. PubMed ID: 39839
[No Abstract] [Full Text] [Related]
18. Cell mediated immune reactions to autologous and homologous tumor tissue in cervical cancer patients.
Koenig UD
Obstet Gynecol Surv; 1979 Nov; 34(11):857-9. PubMed ID: 523041
[No Abstract] [Full Text] [Related]
19. Circulatory and cellular immune responses to squamous cell carcinoma of the uterine cervix.
Chiang WT; Wei PY; Alexander ER
Am J Obstet Gynecol; 1976 Sep; 126(1):116-21. PubMed ID: 786019
[TBL] [Abstract][Full Text] [Related]
20. Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.
Cannon GB; McCoy JL; Jerome LJ; Reddick R; Alford C; Tinley V; Herberman RB
J Natl Cancer Inst; 1978 Nov; 61(5):1181-6. PubMed ID: 280705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
